Newsfeed

This area is a possible form of presentation for the integration of news sources relating to listed companies.
The presentation level is a template based on short news services, where users can get a quick overview of the latest news. The detailed views enable further research if interested.

This newsfeed is a compilation of current news from direct connections of TopTier NewsWire services related to listed companies. This feed is for demonstration purposes only. Sector-specific news, public relations and product information can be accessed via the GICS portals > Sector Intelligence section.

US23918K1088
Reset filter
Do you already know our new terminal view? Click here.
FIGI: BBG000JH3DP2
DVA
DaVita Inc
GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Banks—Regional · THEMEFOLIO: $PLNG
NAME
DaVita Inc
ISIN
US23918K1088
TICKER
DVA
MIC
XNYS
REUTERS
DVA.N
BLOOMBERG
DVA US
Tue, 03.11.2026       Davita
US23918K1088

DaVita Inc. ("DaVita" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in DaVita Inc. (NYSE: DVA), examining whether the Company may have violated the federal securities laws. The investiga...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Davita
US23918K1088

DENVER, Oct. 29, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2026.Financial and operating highlights for the quarter ended September 30, 2026:Consolidated revenues were $3.578 billion.Operating income was $499 million and adjusted operating income was $561 million.Dilut...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 29.10.2026       Davita
US23918K1088

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation co...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 27.10.2026       Davita
US23918K1088

Nearly 1,000 people screened in Houston and Los Angeles, with a majority showing signs of elevated chronic disease riskDENVER, Oct. 27, 2026 /PRNewswire/ -- Millions of Americans are living with chronic disease and don't know it. The risks are often interconnected: High blood pressure and diabetes can increase the risk of kidney disease, while chr...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.10.2026       Davita
US23918K1088

DENVER, Oct. 20, 2026 /PRNewswire/ -- DaVita today issued the following statement in response to the U.S. Department of Health and Human Services' Kidney Care National Plan and related remarks regarding the future of kidney care: DaVita shares the Administration's urgency to accelera...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 19.10.2026       Davita
US23918K1088

DENVER, Oct. 19, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 29, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 15.10.2026       Davita
US23918K1088

Seven studies spanning middle molecule clearance, home dialysis and patient experience highlight DaVita's commitment to translating innovation into better careDENVER, Oct. 15, 2026 /PRNewswire/ -- DaVita will present seven studies at the American Society of Nephrology (ASN) Kidney Week 2026, marking one of its most significant research presences at...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 08.10.2026       Davita
US23918K1088

Patients encouraged to confirm treatment schedules, prepare emergency supplies and contact DaVita for assistanceDENVER, Oct. 8, 2026 /PRNewswire/ -- As Hurricane Isaias approaches the Gulf Coast and southeastern United States, DaVita has activated its emergency response plan to help patients continue receiving life-sustaining dialysis care and to s...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 26.08.2026       Davita
US23918K1088

SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period and up to the date o...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 26.08.2026       Davita
US23918K1088

SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period"). During the Reporting Period and up to the date o...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Tue, 25.08.2026       Davita
US23918K1088

More than 10,000 members will get added support aimed at delaying or preventing dialysis and reducing hospitalizationsDENVER, Aug. 25, 2026 /PRNewswire/ -- DaVita today announced a new value-based care agreement to deliver comprehensive, coordinated care to Humana Medicare Advantage members with chronic kidney disease (CKD) stages 3B–5.Launched Ju...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.08.2026       Davita
US23918K1088

DENVER, Aug. 4, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2026."Thanks to the outstanding efforts of our teammates, we had another positive quarter for both patient outcomes and financial results," said Javier Rodriguez, CEO of DaVita Inc. "As we look to the rest of the ye...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 21.07.2026       Davita
US23918K1088

DENVER, July 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 4, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the D...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 03.06.2026       Davita
US23918K1088

Das Instrument TRL US23918K1088 DAVITA INC. DL -,001 EQUITY hat seinen ersten Handelstag am 04.06.2026: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y The instrument TRL US23918K1088 DAVITA INC. DL -,001 EQUITY has its first trading date on 04.06.2026: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 18.05.2026       Davita
US23918K1088

Kidney care leader launches its next chapter of measurable impact for patients, teammates, and communities.DENVER, May 18, 2026 /PRNewswire/ -- DaVita today announced its 2030 Community Care commitments, a new set of long-term goals, focused on improving patient outcomes, supporting the expansion of economic opportunity for teammates, and strength...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 07.05.2026       Davita
US23918K1088

DENVER, May 6, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at the BofA Securities 2026 Health Care Conference on Tuesday, May 12th, 2026 at 5:20 pm Eastern Daylight Ti...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 05.05.2026       Davita
US23918K1088

DENVER, May 5, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2026."DaVita's foundation is clinical excellence, driven by operating rigor that produces durable results," said Javier Rodriguez, CEO of DaVita Inc. "We have consistently delivered exceptional clinical outcomes and...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.04.2026       Davita
US23918K1088

DENVER, April 20, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 5, 2026, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the DaVi...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 18.03.2026       Davita
US23918K1088

Disclaimer: The statements contained in this document are solely those of the authors and do not necessarily reflect the views or policies of CMS. The authors assume responsibility for the accuracy and completeness of the information contained in this document.DENVER, March 18, 2026 /PRNewswire/ -- DaVita today highlighted continued progress in va...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 24.02.2026       Davita
US23918K1088

DENVER, Feb. 24, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at TD Cowen's 46th Annual Health Care Conference on Monday, March 2, 2026 at 11:50 am EST.To view the live...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Silent Ad
Mon, 02.02.2026       Davita
US23918K1088

DENVER, Feb. 2, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2025."Our strong platform delivered once again in 2025, providing high quality, innovative care to our patients and achieving the financial targets we set out at the beginning of the year despite a chal...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 21.01.2026       Davita
US23918K1088

DENVER, Jan. 21, 2026 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Monday, February 2, 2026 at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.This call is also being webcast and can be accessed at the D...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 11.12.2025       Davita
US23918K1088

Appointments of Chief People Officer and Chief Strategy Officer underscore commitment to innovation and people-first approachDENVER, Dec. 11, 2025 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced two key additions to its executive leadership team: Stephanie Hendrickson has been named Chief People Officer (CPO) an...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Fri, 14.11.2025       Davita
US23918K1088

DENVER, Nov. 14, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat at the Wolfe Research Healthcare Conference on Monday, November 17, 2025, at 11:20 am EST. To view the live webcast, visit the Wolfe Research page here...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 04.11.2025       Davita
US23918K1088

Six  new studies from DaVita Clinical Research spotlight improved outcomes with GLP-1 use, advancements in treatments, transplant access and end-of-life care DENVER and HOUSTON, Nov. 4, 2025 /PRNewswire/ -- DaVita, a steadfast leader in kidney...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 29.10.2025       Davita
US23918K1088

DENVER, Oct. 29, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2025. "Our third quarter performance was in line with our expectations and keeps us on track to achieve our full-year guidance," said Javier Rodriguez, CEO of...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 20.10.2025       Davita
US23918K1088

New U.S. data will offer first-of-its-kind evidence in patients with kidney failure  DENVER, Oct. 20, 2025 /PRNewswire/ -- DaVita today announced the launch of two groundbreaking initiatives aimed to deepen the medical community's understanding of middle-molecule removal and its...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 13.10.2025       Davita
US23918K1088

DENVER, Oct. 13, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Wednesday, October 29, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 27.08.2025       Davita
US23918K1088

Largest kidney care research arm advances science to inform care delivery DENVER, Aug. 27, 2025 /PRNewswire/ -- As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensive kidney care, is proud to spotlight the groundbreaking work of its wholly owned research arm, DaVita Clinical Research (DCR). For a quarter-century,...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 05.08.2025       Davita
US23918K1088

DENVER, Aug. 5, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2025. "We're reporting another solid quarter, fueled by our unwavering focus on patient care," said Javier Rodriguez, CEO of DaVita Inc. "We continued to deliver exceptional clinical outcomes for our patients, fost...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 17.07.2025       Davita
US23918K1088

DENVER, July 17, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 5, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Fri, 30.05.2025       Davita
US23918K1088

DENVER, May 30, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care company, issued the following statement in response to updates this week from the Center for Medicare and Medicaid Innovation (CMMI) related to its Kidney Care Choices (KCC) Model. It can be attributed to Misha Palecek, chief transformation officer for DaVita. "As a dedicat...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.05.2025       Davita
US23918K1088

DENVER, May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes due 2033 (the "2033 notes"). The aggregate principal amount of the 2033 notes offered in the offering was increased from $750 million to $1 billion,...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.05.2025       Davita
US23918K1088

Captures key initiatives achieved in 2024, driving 2025 ESG goals DENVER, May 20, 2025 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental, Social and Governance (ESG) goals set to be achieved...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 20.05.2025       Davita
US23918K1088

DENVER, May 20, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its senior notes due 2033 (the "2033 notes"), subject to market and other conditions. DaVita intends to use the net proceeds from the offering (i) to repay...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 12.05.2025       Davita
US23918K1088

DENVER, May 12, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025. "Our strong first quarter performance demonstrates the stability and consistency of our operating model" said Javier Rodriguez, CEO of DaVita Inc. "We maintain a steadfast commitment to being the provider, e...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 30.04.2025       Davita
US23918K1088

DENVER, April 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Monday, May 12, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the Da...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 06.03.2025       Davita
US23918K1088

DENVER, March 6, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at the Barclays Global Healthcare Conference 2025 on Tuesday, March 11, 2025, at 9:00 a.m. EDT. To view t...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Thu, 30.01.2025       Davita
US23918K1088

DENVER, Jan. 30, 2025 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 13, 2025, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 15.01.2025       Davita
US23918K1088

DENVER, Jan. 15, 2025 /PRNewswire/ -- DaVita, a comprehensive kidney care provider, is celebrating 25 years of clinical care delivery and leadership in healthcare innovation. Since forming with a purpose "to give life" in 2000, DaVita has focused its efforts to improve clinical outcomes, enhance quality of life for patients and be a force for pos...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 12.11.2024       Davita
US23918K1088

More than 8,300 people joined the annual event to raise funds for Bridge of Life DENVER, Nov. 12, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success of its third annual Move It With Purpose (MIWP) event with more than 8,300 participants, including DaVita teammates, friends, family and key members...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Fri, 08.11.2024       Davita
US23918K1088

DENVER, Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST). To...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 29.10.2024       Davita
US23918K1088

DENVER, Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez, CEO of DaVita Inc. "And, in light...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Mon, 28.10.2024       Davita
US23918K1088

The program aims to bring together a supportive network for people dealing with chronic health challenges for themselves and their loved ones DENVER, Oct. 28, 2024 /PRNewswire/ -- The DaVita Giving Foundation today announced an investment in the National Kidney Foundation (NKF)'s PEERS program, a program that provides social and emotional support...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 23.10.2024       Davita
US23918K1088

DENVER and SAN DIEGO, Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the results of five innovative research projects at the American Society of Nephrology (ASN)'s annual Kidney Week meeting, which is currently underway in San Diego...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 22.10.2024       Davita
US23918K1088

Nephrologists drive transformative outcomes through government's coordinated care program serving high-need patients DENVER, Oct. 22, 2024 /PRNewswire/ -- DaVita today announced performance year one clinical outcomes achieved in partnership with nearly 1,300 nephrologists across the U.S. through value-based care arrangements designed to enhance t...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Fri, 11.10.2024       Davita
US23918K1088

TAMPA, Fla., Oct. 11, 2024 /PRNewswire/ -- Following the widespread impact of Hurricane Milton, DaVita Kidney Care dialysis centers have opened their doors to anyone in Florida needing treatment, including those who normally treat at other providers. Dialysis patients may call DaVita Guest Services at 1-800-400-8331 for help locating dialysis cen...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Wed, 09.10.2024       Davita
US23918K1088

DENVER, Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day. This call is also being webcast and can be accessed at the...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 08.10.2024       Davita
US23918K1088

TAMPA, Oct. 8, 2024  /PRNewswire/ -- DaVita Kidney Care, a leading provider of kidney care services, has activated its emergency response plan in preparation for Hurricane Milton's landfall in Florida. DaVita's emergency response plans focus on proactively dialyzing thousands of patients ahead of the storm in more than 150 centers. "Dialy...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink
Tue, 17.09.2024       Davita
US23918K1088

Kidney care leader provides free health screenings and resources to create awareness around kidney disease and open discussion around health care access DENVER, Sept. 17, 2024 /PRNewswire/ -- DaVita (NYSE: DVA), a leading provider of kidney care services, today announced the launch of its 2024 nationwide community health tour beginning September...
Read more
Davita
Technical Analysis Termsheets Terminal
Permalink